AstraZeneca beats top-line and bottom-line estimates initiates FY24 outlook - Seeking Alpha
AZNCF Stock | USD 136.50 1.80 1.34% |
Roughly 51% of AstraZeneca PLC's investor base is interested to short. The analysis of overall sentiment of trading AstraZeneca PLC pink sheet suggests that many investors are impartial at this time. The current market sentiment, together with AstraZeneca PLC's historical and current headlines, can help investors time the market. In addition, many technical investors use AstraZeneca PLC stock news signals to limit their universe of possible portfolio assets.
AstraZeneca PLC pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of AstraZeneca daily returns and investor perception about the current price of AstraZeneca PLC as well as its diversification or hedging effects on your existing portfolios.
AstraZeneca |
AstraZeneca beats top-line and bottom-line estimates initiates FY24 outlook Seeking Alpha
Read at news.google.com
AstraZeneca PLC Fundamental Analysis
We analyze AstraZeneca PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AstraZeneca PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AstraZeneca PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
AstraZeneca PLC is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
AstraZeneca PLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AstraZeneca PLC pink sheet to make a market-neutral strategy. Peer analysis of AstraZeneca PLC could also be used in its relative valuation, which is a method of valuing AstraZeneca PLC by comparing valuation metrics with similar companies.
Peers
AstraZeneca PLC Related Equities
BMYMP | Bristol-Myers Squibb | 19.00 | ||||
ALPMF | Astellas Pharma | 9.50 | ||||
BAYZF | Bayer AG | 1.31 | ||||
ALPMY | Astellas Pharma | 1.18 | ||||
RHHBY | Roche Holding | 0.90 | ||||
NVSEF | Novartis | 0.26 | ||||
RHHVF | Roche Holding | 0.40 | ||||
SNY | Sanofi ADR | 0.47 | ||||
RHHBF | Roche Holding | 1.32 | ||||
DSKYF | Daiichi Sankyo | 5.79 | ||||
GRFS | Grifols SA | 13.38 |
Complementary Tools for AstraZeneca Pink Sheet analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |